Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Walsh

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|May 10, 2015
Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
BMJ Open|October 23, 2021
Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional studyEmma A Hurst, Richard J Mellanby, Ian Handel, et al.
Intensive Care Medicine|October 7, 2018
Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort studyManu Shankar-Hari, Deepankar Datta, Julie Wilson, et al.
Transfusion Medicine Reviews|May 28, 2013
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Thorax|October 10, 2014
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumoniaThomas P Hellyer, Andrew Conway Morris, Daniel F McAuley, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2022
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)Erin E Gaughan, Tom M Quinn, Andrew Mills, et al.
The Lancet. Respiratory Medicine|December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluationThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Nature Medicine|June 17, 2022
Redefining critical illnessDavid M Maslove, Benjamin Tang, Manu Shankar-Hari, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|May 10, 2015
Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
BMJ Open|October 23, 2021
Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional studyEmma A Hurst, Richard J Mellanby, Ian Handel, et al.
Intensive Care Medicine|October 7, 2018
Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort studyManu Shankar-Hari, Deepankar Datta, Julie Wilson, et al.
Transfusion Medicine Reviews|May 28, 2013
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Thorax|October 10, 2014
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumoniaThomas P Hellyer, Andrew Conway Morris, Daniel F McAuley, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2022
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)Erin E Gaughan, Tom M Quinn, Andrew Mills, et al.
The Lancet. Respiratory Medicine|December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluationThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Nature Medicine|June 17, 2022
Redefining critical illnessDavid M Maslove, Benjamin Tang, Manu Shankar-Hari, et al.
Pageof 11